Circulating miRNA-122 levels are associated with hepatic necroinflammation and portal hypertension in HIV/HCV coinfection.
BACKGROUND:Introduction of combined antiretroviral therapy (cART) has improved survival of HIV infected individuals, while the relative contribution of liver-related mortality increased. Especially in HIV/HCV-coinfected patients hepatic fibrosis and portal hypertension represent the main causes of l...
Main Authors: | Christian Jansen, Thomas Reiberger, Jia Huang, Hannah Eischeid, Robert Schierwagen, Mattias Mandorfer, Evrim Anadol, Philipp Schwabl, Carolynne Schwarze-Zander, Ute Warnecke-Eberz, Christian P Strassburg, Jürgen K Rockstroh, Markus Peck-Radosavljevic, Margarete Odenthal, Jonel Trebicka |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4315411?pdf=render |
Similar Items
-
The role of miRNA-34a as a prognostic biomarker for cirrhotic patients with portal hypertension receiving TIPS.
by: Christian Jansen, et al.
Published: (2014-01-01) -
Exposure to previous cART is associated with significant liver fibrosis and cirrhosis in human immunodeficiency virus-infected patients.
by: Evrim Anadol, et al.
Published: (2018-01-01) -
Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)
by: Jenny Bischoff, et al.
Published: (2021-10-01) -
Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?
by: Tilman Sauerbruch, et al.
Published: (2023-01-01) -
Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART.
by: Leona Dold, et al.
Published: (2019-01-01)